• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天花和猴痘的治疗和疫苗接种。

Treatment and Vaccination for Smallpox and Monkeypox.

机构信息

Biosecurity Research at Section Political Science of the Department of Cultural and Social Sciences, University of Osnabrueck, Osnabrueck, Germany.

出版信息

Adv Exp Med Biol. 2024;1451:301-316. doi: 10.1007/978-3-031-57165-7_19.

DOI:10.1007/978-3-031-57165-7_19
PMID:38801586
Abstract

The smallpox infection with the variola virus was one of the most fatal disorders until a global eradication was initiated in the twentieth century. The last cases were reported in Somalia 1977 and as a laboratory infection in the UK 1978; in 1980, the World Health Organization (WHO) declared smallpox for extinct. The smallpox virus with its very high transmissibility and mortality is still a major biothreat, because the vaccination against smallpox was stopped globally in the 1980s. For this reason, new antivirals (cidofovir, brincidofovir, and tecovirimat) and new vaccines (ACAM2000, LC16m8 and Modified Vaccine Ankara MVA) were developed. For passive immunization, vaccinia immune globulin intravenous (VIGIV) is available. Due to the relationships between orthopox viruses such as vaccinia, variola, mpox (monkeypox), cowpox, and horsepox, the vaccines (LC16m8 and MVA) and antivirals (brincidofovir and tecovirimat) could also be used in the mpox outbreak with positive preliminary data. As mutations can result in drug resistance against cidofovir or tecovirimat, there is need for further research. Further antivirals (NIOCH-14 and ST-357) and vaccines (VACΔ6 and TNX-801) are being developed in Russia and the USA. In conclusion, further research for treatment and prevention of orthopox infections is needed and is already in progress. After a brief introduction, this chapter presents the smallpox and mpox disease and thereafter full overviews on antiviral treatment and vaccination including the passive immunization with vaccinia immunoglobulins.

摘要

天花感染痘病毒是 20 世纪全球开始消灭天花之前最致命的疾病之一。最后一例报告于 1977 年在索马里,1978 年在英国实验室感染;1980 年,世界卫生组织(WHO)宣布天花已灭绝。由于天花疫苗在 20 世纪 80 年代在全球范围内停止接种,因此天花病毒仍然是一种主要的生物威胁,其具有非常高的传染性和死亡率。为此,开发了新的抗病毒药物(西多福韦、布西福韦和特考韦瑞玛)和新的疫苗(ACAM2000、LC16m8 和改良痘苗安卡拉 MVA)。对于被动免疫,有天花免疫球蛋白静脉注射(VIGIV)。由于正痘病毒(如牛痘、天花、猴痘、牛痘和马痘)之间的关系,疫苗(LC16m8 和 MVA)和抗病毒药物(布西福韦和特考韦瑞玛)也可用于猴痘爆发,初步数据为阳性。由于突变可能导致西多福韦或特考韦瑞玛耐药,因此需要进一步研究。俄罗斯和美国正在开发其他抗病毒药物(NIOCH-14 和 ST-357)和疫苗(VACΔ6 和 TNX-801)。总之,需要进一步研究治疗和预防正痘感染的方法,目前正在进行中。在简要介绍之后,本章介绍了天花和猴痘疾病,然后全面介绍了抗病毒治疗和疫苗接种,包括天花免疫球蛋白的被动免疫。

相似文献

1
Treatment and Vaccination for Smallpox and Monkeypox.天花和猴痘的治疗和疫苗接种。
Adv Exp Med Biol. 2024;1451:301-316. doi: 10.1007/978-3-031-57165-7_19.
2
Poxvirus Vaccines: Past, Present, and Future.痘病毒疫苗:过去、现在和未来。
Adv Exp Med Biol. 2024;1451:273-287. doi: 10.1007/978-3-031-57165-7_17.
3
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.人类正痘病毒感染的治疗策略:猴痘(mpox)、天花、软疣痘和羊痘。
Travel Med Infect Dis. 2023 Mar-Apr;52:102528. doi: 10.1016/j.tmaid.2022.102528. Epub 2022 Dec 17.
4
Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.使用天花抗病毒药物tecovirimat(ST-246)单独治疗或与ACAM2000疫苗联合治疗,作为猴痘病毒感染的症状出现后疗法是有效的。
Antimicrob Agents Chemother. 2015 Jul;59(7):4296-300. doi: 10.1128/AAC.00208-15. Epub 2015 Apr 20.
5
Emerging pharmacological strategies for treating and preventing mpox.治疗和预防猴痘的新兴药理学策略。
Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(9):843-854. doi: 10.1080/17512433.2023.2249820. Epub 2023 Aug 22.
6
Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.在非人类灵长类动物中联合使用特考韦瑞玛特和 ACAM2000TM:特考韦瑞玛特治疗对 ACAM2000 免疫原性和针对致死性猴痘病毒攻击的疗效的影响。
Vaccine. 2020 Jan 16;38(3):644-654. doi: 10.1016/j.vaccine.2019.10.049. Epub 2019 Oct 31.
7
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.天花潜在治疗药物溴昔洛韦的药代动力学和疗效在致命猴痘病毒动物模型中的研究。
mSphere. 2021 Feb 3;6(1):e00927-20. doi: 10.1128/mSphere.00927-20.
8
Monkeypox: A re-emerging disease.猴痘:一种再现的疾病。
Indian J Pharmacol. 2024 Mar 1;56(2):129-135. doi: 10.4103/ijp.ijp_156_23. Epub 2024 Apr 30.
9
The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.布立尼度福韦在应对天花潜在爆发中的作用。
Viruses. 2017 Oct 30;9(11):320. doi: 10.3390/v9110320.
10
A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.一种用于评估抗猴痘病毒预防药物和治疗药物的致死性感染小鼠模型。
J Virol. 2010 Apr;84(8):3909-20. doi: 10.1128/JVI.02012-09. Epub 2010 Feb 3.

引用本文的文献

1
Global epidemiology, viral evolution, and public health responses: a systematic review on Mpox (1958-2024).全球流行病学、病毒进化与公共卫生应对:关于猴痘的系统综述(1958 - 2024年)
J Glob Health. 2025 Mar 7;15:04061. doi: 10.7189/jogh.15.04061.
2
Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines.下一代山羊痘病毒和猴痘病毒疫苗的研发方法。
Viruses. 2025 Jan 27;17(2):186. doi: 10.3390/v17020186.
3
Current advances and challenges in mpox vaccine development: a global landscape.猴痘疫苗研发的当前进展与挑战:全球概况

本文引用的文献

1
Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.特考韦瑞与猴痘治疗——过去、现在及未来考量
N Engl J Med. 2022 Aug 18;387(7):579-581. doi: 10.1056/NEJMp2210125. Epub 2022 Aug 3.
2
Clinical features and management of human monkeypox: a retrospective observational study in the UK.英国一项回顾性观察研究:人类猴痘的临床特征和管理。
Lancet Infect Dis. 2022 Aug;22(8):1153-1162. doi: 10.1016/S1473-3099(22)00228-6. Epub 2022 May 24.
3
Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus.
Ther Adv Vaccines Immunother. 2025 Jan 27;13:25151355251314339. doi: 10.1177/25151355251314339. eCollection 2025.
BALB/c 小鼠对牛痘病毒 LIVP 感染的适应性免疫反应及对致死性重新感染牛痘病毒的保护作用。
Viruses. 2021 Aug 17;13(8):1631. doi: 10.3390/v13081631.
4
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.特考韦瑞玛治疗天花概述及拓展的抗正痘病毒应用。
Expert Rev Anti Infect Ther. 2021 Mar;19(3):331-344. doi: 10.1080/14787210.2020.1819791. Epub 2020 Sep 15.
5
Access and benefit-sharing following the synthesis of horsepox virus.马痘病毒合成后的获取与惠益分享。
Nat Biotechnol. 2020 May;38(5):537-539. doi: 10.1038/s41587-020-0518-z.
6
The development and approval of tecoviromat (TPOXX), the first antiviral against smallpox.天花病毒的第一种抗病毒药物特考韦瑞(TPOXX)的研发与获批。
Antiviral Res. 2019 Aug;168:168-174. doi: 10.1016/j.antiviral.2019.06.005. Epub 2019 Jun 7.
7
Synthetic viruses-Anything new?合成病毒——有什么新情况吗?
PLoS Pathog. 2018 Oct 4;14(10):e1007019. doi: 10.1371/journal.ppat.1007019. eCollection 2018 Oct.
8
Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin.抗生素利福平抑制痘病毒装配的结构基础。
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8424-8429. doi: 10.1073/pnas.1810398115. Epub 2018 Aug 1.
9
Oral Tecovirimat for the Treatment of Smallpox.口服特考韦瑞玛用于天花的治疗。
N Engl J Med. 2018 Jul 5;379(1):44-53. doi: 10.1056/NEJMoa1705688.
10
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections.针对痘病毒感染的交叉中和及保护性人类抗体特异性
Cell. 2016 Oct 20;167(3):684-694.e9. doi: 10.1016/j.cell.2016.09.049.